Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02220413 · ClinicalTrials.gov registry record
Predictors of Lactogenesis II
A clinical trial, sponsored by University of South Florida.
- Completed
- Registry status
- 216
- Enrollment target
NCT02220413 is a clinical trial that has completed, run by University of South Florida. The registered enrollment target is 216 participants.
The verdict
NCT02220413 has completed, sponsored by University of South Florida.
- COMPLETED
- Registry status
- 216 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate what proportion of obese women will have a self-reported delay in lactogenesis II ("breastmilk coming in") compared to women with a normal weight. We hypothesize that obese women will have an absolute 20% increase in delayed lactogenesis II. We will compare two group of women for delayed lactogenesis II, one group with obese women (BMI\>30) and one group of women with a normal weight (BMI\<30). The secondary objective is to assess what other factors influence the self-reported delayed lactogenesis II.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 216 participants |
| Start Date | 2014-08 |
| Est. Completion | 2017-01-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02220413
The ClinicalTrials.gov registry entry for NCT02220413 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 216 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of South Florida, which has 252 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02220413 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02220413 about?
NCT02220413 is a clinical study titled "Predictors of Lactogenesis II". The purpose of this study is to investigate what proportion of obese women will have a self-reported delay in lactogenesis II ("breastmilk coming in") compared to women with a normal weight. We hypothesize that obese women will have an absolute 20% increase in delayed lactogenesis II. We will compa...
What is the current status of trial NCT02220413?
This trial is currently completed. The enrollment target is 216 participants. The study started on 2014-08. Estimated completion is 2017-01-01.
Who is sponsoring clinical trial NCT02220413?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.